Randomized Clinical Trial to Evaluate the Morphological Changes in the Adventitial Vasa Vasorum Density and Biological Markers of Endothelial Dysfunction in Subjects with Moderate Obesity Undergoing a Very Low-Calorie Ketogenic Diet.
Adult
Adventitia
/ pathology
Biomarkers
/ blood
Carotid Arteries
/ diagnostic imaging
Cholesterol, HDL
/ blood
Diet, Ketogenic
/ methods
Diet, Reducing
/ methods
Endothelial Cells
/ pathology
Female
Humans
Intercellular Adhesion Molecule-1
/ blood
Male
Middle Aged
Obesity
/ blood
Plaque, Atherosclerotic
/ blood
Quality of Life
Surveys and Questionnaires
Ultrasonography
/ methods
Vasa Vasorum
/ diagnostic imaging
Vascular Cell Adhesion Molecule-1
/ blood
multidisciplinary approach
obesity
pronokal method
vasa vasorum
very low calorie ketogenic diet
weight loss
Journal
Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595
Informations de publication
Date de publication:
23 Dec 2021
23 Dec 2021
Historique:
received:
26
11
2021
revised:
18
12
2021
accepted:
20
12
2021
entrez:
11
1
2022
pubmed:
12
1
2022
medline:
27
1
2022
Statut:
epublish
Résumé
Weight loss after bariatric surgery decreases the earlier expansion of the adventitial vasa vasorum (VV), a biomarker of early atheromatous disease. However, no data are available regarding weight loss achieved by very low calorie ketogenic diets (VLCKD) on VV and lipid-based atherogenic indices. A randomized clinical trial was performed to examine changes in adventitial VV density in 20 patients with moderate obesity who underwent a 6-month very low calorie ketogenic diet (VLCKD, 600-800 kcal/day), and 10 participants with hypocaloric diet based on the Mediterranean Diet (MedDiet, estimated reduction of 500 kcal on the usual intake). Contrast-enhanced carotid ultrasound was used to assess the VV. Body composition analysis was also used. The atherogenic index of plasma (log (triglycerides to high-density lipoprotein cholesterol ratio)) and the triglyceride-glucose index were calculated. Serum concentrations of soluble intercellular adhesion molecule 1 (sICAM-1), and soluble vascular cell adhesion molecule 1 (sVCAM-1) were measured. The impact of weight on quality of life-lite (IWQOL-Lite) questionnaire was administered. Participants of intervention groups displayed a similar VV values. Significant improvements of BMI (-5.3 [-6.9 to -3.6] kg/m
Identifiants
pubmed: 35010908
pii: nu14010033
doi: 10.3390/nu14010033
pmc: PMC8746664
pii:
doi:
Substances chimiques
Biomarkers
0
Cholesterol, HDL
0
Vascular Cell Adhesion Molecule-1
0
Intercellular Adhesion Molecule-1
126547-89-5
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : PronoKal Group (Spain)
Références
Rev Esp Cardiol (Engl Ed). 2016 Jun;69(6):579-87
pubmed: 27133458
Nutrients. 2018 Sep 21;10(10):
pubmed: 30241426
Int J Mol Sci. 2015 May 20;16(5):11574-608
pubmed: 26006236
Am J Physiol. 1981 May;240(5):H781-7
pubmed: 7235037
Arch Med Res. 2019 Jul;50(5):285-294
pubmed: 31593853
Nutrients. 2020 Sep 09;12(9):
pubmed: 32916989
Lancet. 2016 Apr 2;387(10026):1377-1396
pubmed: 27115820
Eur Rev Med Pharmacol Sci. 2016 Jul;20(12):2613-21
pubmed: 27383313
Biomedicines. 2020 Aug 25;8(9):
pubmed: 32854210
Obes Res. 2004 Nov;12 Suppl 2:115S-23S
pubmed: 15601959
Circulation. 2002 Aug 13;106(7):820-5
pubmed: 12176954
Biomed Res Int. 2014;2014:701571
pubmed: 24724094
Surg Obes Relat Dis. 2020 Oct;16(10):1419-1428
pubmed: 32694041
Cardiovasc Diabetol. 2018 May 1;17(1):56
pubmed: 29712560
Rev Endocr Metab Disord. 2020 Sep;21(3):381-397
pubmed: 32803691
Front Immunol. 2018 Apr 17;9:706
pubmed: 29719532
JAMA. 2014 Feb 26;311(8):806-14
pubmed: 24570244
Circulation. 2005 Aug 16;112(7):976-83
pubmed: 16087797
Angiology. 2017 Jul;68(6):472-493
pubmed: 27568384
BMC Med. 2010 Mar 24;8:18
pubmed: 20334633
J Am Med Dir Assoc. 2011 May;12(4):249-56
pubmed: 21527165
Arterioscler Thromb Vasc Biol. 2020 Nov;40(11):2569-2576
pubmed: 32878476
Endocrine. 2016 Oct;54(1):111-122
pubmed: 27117144
Rev Endocr Metab Disord. 2020 Mar;21(1):1-3
pubmed: 32080796
J Thorac Dis. 2018 Nov;10(11):6137-6146
pubmed: 30622785
Am J Physiol Cell Physiol. 2017 Nov 1;313(5):C567-C574
pubmed: 28814403
Clin Nutr. 2010 Apr;29(2):154-9
pubmed: 20060626
Can J Cardiol. 2015 Feb;31(2):184-94
pubmed: 25661553
Qual Life Res. 2002 Mar;11(2):157-71
pubmed: 12018739
Front Nutr. 2021 Jul 16;8:702802
pubmed: 34336911
Lancet Public Health. 2018 Oct;3(10):e490-e497
pubmed: 30177479
Age Ageing. 2019 Jul 1;48(4):601
pubmed: 31081853
Clin Cases Miner Bone Metab. 2014 Sep;11(3):177-80
pubmed: 25568649
Circulation. 2004 Oct 5;110(14):2032-8
pubmed: 15451780
Cardiovasc Ultrasound. 2015 Apr 17;13:20
pubmed: 25889409
Drug Discov Today. 2016 Oct;21(10):1578-1595
pubmed: 27265770
Front Endocrinol (Lausanne). 2020 Sep 14;11:607
pubmed: 33042004
Arterioscler Thromb Vasc Biol. 2014 Aug;34(8):1723-30
pubmed: 24947528
J Clin Endocrinol Metab. 2017 Feb 1;102(2):488-498
pubmed: 27754807
Physiol Genomics. 2013 Aug 15;45(16):697-709
pubmed: 23737535
Obes Surg. 2018 Dec;28(12):3935-3942
pubmed: 30030728
PLoS One. 2019 Feb 5;14(2):e0211742
pubmed: 30721271
Nutrients. 2019 Jun 17;11(6):
pubmed: 31212934
J Endocrinol Invest. 2019 Nov;42(11):1365-1386
pubmed: 31111407
Curr Obes Rep. 2018 Dec;7(4):276-288
pubmed: 30155850
Minerva Endocrinol (Torino). 2021 Jun;46(2):161-167
pubmed: 33213120
Rev Endocr Metab Disord. 2020 Mar;21(1):5-16
pubmed: 31705259
Eur Cardiol. 2021 May 17;16:e20
pubmed: 34093741
Obes Facts. 2021;14(2):222-245
pubmed: 33882506
Lipids. 2008 Jan;43(1):65-77
pubmed: 18046594